Peripheral vs Central Access for Vasopressors: What Did the VIPCA Trial Find?
19 November 2025
Study OverviewThe VIPCA trial (Vasopressor Infusion via Peripheral Cannula vs Central Access) was a single-centre, randomised, controlled feasibility study conducted in a Queensland ICU. Forty crit...
The Michigan Appropriateness Guide for IV Catheters in Adult Cancer (MAGIC-ONC) — Guideline Snapshot
14 November 2025
Study OverviewSafe venous access underpins cancer care, yet device choice (PIV, midline, PICC, tunneled CVC, port) can alter risks of CLABSI and VTE. MAGIC-ONC provides consensus, evidence-informed...
Preventing CVAD Infections: What Should We Test Next?
12 November 2025
Central venous access devices (CVADs) are essential in healthcare but come with a serious risk: bloodstream infections. With so many potential interventions—and limited high-quality evidence—wh...
Flushing Peripheral Intravenous Catheters – What Do We Really Know?
5 November 2025
Study Overview:
Peripheral intravenous catheter (PIVC) flushing is a common nursing practice aimed at preventing occlusion and ensuring line patency. However, there’s no consistent, evidence-bas...
Empowering Patients at Home: Co-Designing a PICC Booklet
29 October 2025
Study OverviewThis study focused on the co-design and evaluation of an educational booklet titled “Living Well With a PICC at Home”, aimed at improving home-based care and management for patien...
Mapping the Evidence: Gaps in Central Venous Access Device Trials
26 October 2025
Study OverviewThis evidence and gap map (EGM) provides a comprehensive overview of clinical trials conducted in the area of central venous access devices (CVADs). The study aimed to visualise the q...

Address

Griffith University
Nathan
Queensland
Australia 4111